ACHVAchieve Life Sciences, Inc.
$7.18+116% 1Y
$7.18
$2.6552 weeks$8.54
ACHV as reported
- Net income
- −$114M
Net income · +126% year on year · trailing twelve months to Q2 2026
- EPS
- −$1.53
EPS · +4.8% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$114M | +126% | Q2 2026 |
| EPS | −$1.53 | +4.8% | Q2 2026 |
| ROE | −30% | n/a | Q2 2026 |
| ROA | −112% | n/a | Q2 2026 |
| Free cash flow | −$13M | n/a | Q4 2020 · 22 quarters behind |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Achieve Life Sciences, Inc. (ACHV) · Net incomeNet incomeAchieve Life Sciences, Inc. (ACHV)